11-62594993-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004739.4(MTA2):c.1561G>A(p.Val521Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000247 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004739.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTA2 | NM_004739.4 | c.1561G>A | p.Val521Ile | missense_variant | Exon 15 of 18 | ENST00000278823.7 | NP_004730.2 | |
MTA2 | NM_001330292.2 | c.1042G>A | p.Val348Ile | missense_variant | Exon 15 of 18 | NP_001317221.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTA2 | ENST00000278823.7 | c.1561G>A | p.Val521Ile | missense_variant | Exon 15 of 18 | 1 | NM_004739.4 | ENSP00000278823.2 | ||
MTA2 | ENST00000524902.5 | c.1042G>A | p.Val348Ile | missense_variant | Exon 13 of 16 | 1 | ENSP00000431346.1 | |||
MTA2 | ENST00000527204.5 | c.1042G>A | p.Val348Ile | missense_variant | Exon 15 of 18 | 2 | ENSP00000431797.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251420Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135892
GnomAD4 exome AF: 0.000259 AC: 378AN: 1461788Hom.: 0 Cov.: 31 AF XY: 0.000268 AC XY: 195AN XY: 727196
GnomAD4 genome AF: 0.000138 AC: 21AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1561G>A (p.V521I) alteration is located in exon 15 (coding exon 15) of the MTA2 gene. This alteration results from a G to A substitution at nucleotide position 1561, causing the valine (V) at amino acid position 521 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at